Łukasz Bułdak

Metformin affects macrophages’ phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages

Łukasz Bułdak, Krzysztof Łabuzek, Rafał Jakub Bułdak et al. · Pharmacological Reports · 2014 · 105 citations

Life Sciences, Cell Biology, Immunology +17

Short‐term exposure to 50 Hz ELF‐EMF alters the cisplatin‐induced oxidative response in AT478 murine squamous cell carcinoma cells

Rafał Jakub Bułdak, Renata Polaniak, Łukasz Bułdak et al. · Bioelectromagnetics · 2012 · 69 citations

Life Sciences, Oncology, Toxicology +17

Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner

Łukasz Bułdak, Grzegorz Machnik, Rafał Jakub Bułdak et al. · Pharmacological Reports · 2015 · 69 citations

Life Sciences, Cell Biology, Pharmacology +16

Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: An in vitro study

Rafał Jakub Bułdak, Łukasz Bułdak, Renata Polaniak et al. · Oncology Reports · 2012 · 55 citations

Life Sciences, Cell Biology, Oncology +11

Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling

Łukasz Bułdak, Grzegorz Machnik, Rafał Jakub Bułdak et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2016 · 54 citations

Life Sciences, Immunology, Pharmacology +14